Treatment of Chronic Fatigue Syndrome and Fibromyalgia With D-ribose- a Multicenter Study
NCT01108549 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 257
Last updated 2010-04-22
Summary
To determine whether adding Ribose 5 grams 3 x day would improve quality of life, energy, sleep and cognitive function and decrease pain in patients with CFS and/or fibromyalgia (CFS/FMS).
Conditions
- Fibromyalgia
- Chronic Fatigue Syndrome
Interventions
- DIETARY_SUPPLEMENT
-
Ribose
Ribose 5 grams PO TID was taken daily
Sponsors & Collaborators
-
Bioenergy Life Science, Inc.
collaborator INDUSTRY -
Integrative Therapeutics, Inc.
collaborator INDUSTRY -
Kona Research Center
lead OTHER
Principal Investigators
-
Jacob E Teitelbaum, MD · Kona Research Center
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2009-09-30
- Completion
- 2009-09-30
Countries
- United States
Study Locations
More Related Trials
-
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
NCT02234583 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Fibromyalgia With Recovery Factors
NCT04381780 ·Status: COMPLETED ·Phase: NA
-
A Study of Duloxetine in the Treatment of Fibromyalgia
NCT00125892 ·Status: COMPLETED ·Phase: PHASE3
-
Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia : A 13-week Randomized, Placebo Controlled Cross Over Trial
NCT01829243 ·Status: COMPLETED ·Phase: PHASE3
-
Fibromyalgia Health Outcome Study on Cost of Treatments
NCT00725101 ·Status: COMPLETED
-
A Study to Evaluate the Effects of Milnacipran on Pain Processing and Functional MRI in Patients With Fibromyalgia
NCT01173055 ·Status: COMPLETED ·Phase: PHASE4
-
L-Tyrosine Supplementation in Patients With Fibromyalgia
NCT01219049 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Magnetic Fields to Treat Fibromyalgia
NCT01262131 ·Status: COMPLETED ·Phase: PHASE2
-
The Innate Central Nervous System Immune Response to an Experimental Immune Challenge in People With Fibromyalgia
NCT04263454 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment of Pain Associated With Fibromyalgia
NCT02187159 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia
NCT00754221 ·Status: TERMINATED ·Phase: PHASE3
-
Psilocybin-facilitated Treatment for Chronic Pain
NCT05068791 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study of Duloxetine in Fibromyalgia
NCT01552057 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
NCT00752505 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Revival Soy on Fibromyalgia Pain
NCT00279942 ·Status: COMPLETED ·Phase: NA
-
A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia
NCT00357825 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effect of Rhythmic Sensory Stimulation on Fibromyalgia
NCT02493348 ·Status: COMPLETED ·Phase: NA
-
An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057)
NCT01621191 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome
NCT00190866 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Milnacipran for the Treatment of Fibromyalgia
NCT00314249 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Susceptibility to Placebo on the Effect of Transcranial Direct Current Stimulation (tDCS) in Fibromyalgia
NCT05845528 ·Status: COMPLETED ·Phase: NA
-
Neurotropin Treatment of Fibromyalgia
NCT00366535 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation and Diagnosis of People With Pain and Fatigue Syndromes
NCT00677157 ·Status: COMPLETED
-
Duloxetine Metabolism and Fibromyalgia
NCT06866444 ·Status: RECRUITING
-
Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia
NCT01077375 ·Status: COMPLETED ·Phase: PHASE4